Creating a database for cancer research and treatment
Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas
This study is creating a detailed database to help researchers understand different types of cancer better and improve treatments for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03449264 on ClinicalTrials.gov |
What this trial studies
This project aims to develop a comprehensive clinical and biological database to support research in various types of cancer, including digestive, gynecologic, breast cancer, and sarcoma. It focuses on collecting high-quality biological samples and clinical data to enhance understanding of tumor behavior and treatment responses. The initiative is part of a national health strategy to integrate research with clinical practice, ultimately benefiting patient care and advancing therapeutic innovations. By establishing a multidisciplinary framework, the project seeks to facilitate data sharing among researchers for improved cancer management.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with invasive or in situ tumors of specific cancer types who are treatment-naïve and require surgical intervention.
Not a fit: Patients who are not affiliated with a social protection scheme or those unable to maintain regular follow-up due to various reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to better prevention, diagnosis, and treatment strategies for various cancer types.
How similar studies have performed: Other studies have shown success in utilizing similar database approaches for cancer research, indicating a promising avenue for future advancements.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age\> at 18 years old, * Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded, * Patient in ICM at diagnosis * a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or * gynecological cancer (ovary, endometrium, cervix) or * breast cancer or * sarcoma. * Naïve patient of any treatment for the present cancer, * Patient requiring treatment involving at least one (or more) tumor surgery (s) * Patient who has accepted supplementary blood samples, * Patient having given his informed, written and express consent. Exclusion Criteria: * Patient not affiliated to a social protection scheme, * Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons, * Pregnant and / or nursing women, * Subject under tutelage, curatorship or safeguard of justice, * Patient in an emergency situation.
Where this trial is running
Montpellier
- Institut regional du Cancer - Val d Aurelle — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: david azria
- Email: david.azria@icm.unicancer.fr
- Phone: +33467613102
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.